Articles

Article

How can new approaches to digitalisation help keep the patient experience in focus?

How can new approaches to digitalisation help keep the patient experience in focus?

As the practices in which clinical trials are conducted and monitored continue to modernise at a rapid pace, there is an urgent need for digital transformation in the industry.  Encapsia’s Temitope Keyes speaks to International Clinical Trials about new approaches to digitalisation that can help patient experience in focus.

Read more on ICT.

Article

Oncology Decentralized Trials call for special consideration: Encapsia

Oncology Decentralized Trials call for special consideration: Encapsia

Encapsia spoke to Outsourcing-Pharma about some of the challenges unique to cancer-focused DCTs, and technologies that can help overcome some of these special obstacles.

Read more on Outsourcing Pharma

Article

The Source and the Story – How Digital Transformation Truly Centers Patients

The Source and the Story – How Digital Transformation Truly Centers Patients

This article is taken from International Clinical Trials February 2022, pages 8-10 © Samedan Ltd

Article

Predictions and perspectives on the future of DCTs

Predictions and perspectives on the future of DCTs

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.

Read more on Drug Discovery World

Article

Updates Ready: Reboot Necessary

Updates Ready: Reboot Necessary

Clinical trials are now more complex than ever, and technology has not kept pace. Though a shift to digital decentralization has begun, all too often the solutions are just stitched onto already underperforming legacy systems.

Read more on The Medicine Maker

Article

Getting the right tech tools vital to decentralized trial transition

Getting the right tech tools vital to decentralized trial transition

Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

Read more on Outsourcing Pharma

Article

Enabling Decentralized Clinical Trials through Digital Transformation

Enabling Decentralized Clinical Trials through Digital Transformation

To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.

Read more on Contract Pharma

Article

Personalized Medicine: A Work in Progress

Personalized Medicine: A Work in Progress

Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.

Read more on PharmaVoice

Article

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.

Latest articles

Minimizing Disruption Through Hybrid Clinical Trial Adoption

There have been significant disruptions in the healthcare industry in recent years, particularly in the conduct of clinical trials. The traditional, centralized model of clinical trial design has faced significant challenges in terms of patient recruitment, retention, and overall operational…

Read article

Employee Spotlight: Women in Tech

Q&A with encapsia’s Executive Director of Business Development Temitope Keyes   Superior innovation and performance are achieved with diverse teams that bring new perspectives and skill sets. In acknowledgment of International Women’s Day, we’re shining the spotlight on women in…

Read article

Delayed Clinical Data and Its Impact

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Read article